Does Transient Opioid Use Increase Risk of Short-Term Respiratory Exacerbation among Older Adults with Chronic Obstructive Pulmonary Disease?

References

• COPD Trends Brief [Internet]. [cited 2021 Aug 11]. Available from: https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief.
   Google Scholar
• Kobayashi S, Yanai M, Hanagama M, et al. The burden of chronic obstructive pulmonary disease in the elderly population. Respiratory Investig. 2014;52(5):296–301. DOI:https://doi.org/10.1016/j.resinv.2014.04.005
   PubMedGoogle Scholar
• Heffner JE, Highland KB. Chronic obstructive pulmonary disease in geriatric critical care. Crit Care Clin. 2003;19(4):713–727. DOI:https://doi.org/10.1016/S0749-0704(03)00054-X
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 Report. [accessed July 15, 2021]. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.
   Google Scholar
• Burt L, Corbridge S. COPD exacerbations. Am J Nurs. 2013;113(2):34–43; quiz 44. DOI:https://doi.org/10.1097/01.NAJ.0000426688.96330.60
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. DOI:https://doi.org/10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Shah T, Press VG, Huisingh-Scheetz M, et al. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150(4):916–926. DOI:https://doi.org/10.1016/j.chest.2016.05.002
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. DOI:https://doi.org/10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Morbidity & mortality: 2012 chart book on cardiovascular, lung, and blood diseases. Bethesda (MD): National Heart, Lung, and Blood Institute; 2012.
   Google Scholar
• Genao L, Durheim MT, Mi X, et al. Early and long-term outcomes of older adults after acute care encounters for chronic obstructive pulmonary disease exacerbation. Ann Am Thorac Soc. 2015;12(12):1805–1812. DOI:https://doi.org/10.1513/AnnalsATS.201504-250OC
   PubMed Web of Science ®Google Scholar
• Seemungal TAR, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD-a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203–223. DOI:https://doi.org/10.2147/copd.s3385
   PubMedGoogle Scholar
• Halpin DM, Miravitlles M, Metzdorf N, et al. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. DOI:https://doi.org/10.2147/COPD.S139470
   PubMed Web of Science ®Google Scholar
• Pavord ID, Jones PW, Burgel P-R, et al. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11 Spec Iss:21–30. DOI:https://doi.org/10.2147/COPD.S85978
   PubMed Web of Science ®Google Scholar
• Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(9):e56–e69. DOI:https://doi.org/10.1164/rccm.202003-0625ST
   PubMed Web of Science ®Google Scholar
• Ekström M, Nilsson F, Abernethy AA, et al. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015;12(7):1079–1092. DOI:https://doi.org/10.1513/AnnalsATS.201501-034OC
   PubMed Web of Science ®Google Scholar
• Samp JC, Joo MJ, Schumock GT, et al. Predicting acute exacerbations in chronic obstructive pulmonary disease. J Manag Care Spec Pharm. 2018;24(3):265–279. DOI:https://doi.org/10.18553/jmcp.2018.24.3.265
   PubMed Web of Science ®Google Scholar
• Ekström MP, Bornefalk-Hermansson A, Abernethy AP, et al. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014;348:g445. DOI:https://doi.org/10.1136/bmj.g445
   PubMed Web of Science ®Google Scholar
• Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2016;48(3):683–693. DOI:https://doi.org/10.1183/13993003.01967-2015
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624–1645. DOI:https://doi.org/10.1001/jama.2016.1464
   PubMed Web of Science ®Google Scholar
• Pattinson KTS. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747–758. DOI:https://doi.org/10.1093/bja/aen094
   PubMed Web of Science ®Google Scholar
• Taylor S, Kirton OC, Staff I, et al. Postoperative day one: a high risk period for respiratory events. Am J Surg. 2005;190(5):752–756. DOI:https://doi.org/10.1016/j.amjsurg.2005.07.015
   PubMed Web of Science ®Google Scholar
• Gupta K, Prasad A, Nagappa M, et al. Risk factors for opioid-induced respiratory depression and failure to rescue: a review. Curr Opin Anaesthesiol. 2018;31(1):110–119. DOI:https://doi.org/10.1097/ACO.0000000000000541
   PubMed Web of Science ®Google Scholar
• Kessler ER, Shah M, Gruschkus SK, et al. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013;33(4):383–391. DOI:https://doi.org/10.1002/phar.1223
   PubMed Web of Science ®Google Scholar
• Rong Y, Bentley JP, McGwin G, et al. Association between transient opioid use and short-term respiratory exacerbation among adults with chronic obstructive pulmonary disease: a case-crossover study. Am J Epidemiol. 2019;188(11):1970–1976. DOI:https://doi.org/10.1093/aje/kwz169
   PubMed Web of Science ®Google Scholar
• Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease: “I was worried that he didn’t have much room to decline.” JAMA. 2012;308(12):1254. DOI:https://doi.org/10.1001/jama.2012.12422
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Salkar M, Bentley JP, et al. Pattern of use and geographic variation in long-term prescription opioid use among older adults in the United States: a study of medicare administrative claims data. Pain Physician. 2021;24(1):31–40.
   PubMed Web of Science ®Google Scholar
• Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144–153. DOI:https://doi.org/10.1093/oxfordjournals.aje.a115853
   PubMed Web of Science ®Google Scholar
• Cadarette SM, Maclure M, Delaney JC, et al. Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2021;30(6):671–684. DOI:https://doi.org/10.1002/pds.5227
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Calculating total daily dose of opioids for safer dosage [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; [cited 2021 May 21]. Available from: https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf.
   Google Scholar
• Luo X, Sorock GS. Analysis of recurrent event data under the case-crossover design with applications to elderly falls . Stat Med. 2008;27(15):2890–2901. DOI:https://doi.org/10.1002/sim.3171
   PubMed Web of Science ®Google Scholar
• Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(10):265–269. DOI:https://doi.org/10.15585/mmwr.mm6610a1
   PubMed Web of Science ®Google Scholar
• Le TT, Park S, Choi M, et al. Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2020.
   PubMed Web of Science ®Google Scholar
• Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112(1):226–238. DOI:https://doi.org/10.1097/ALN.0b013e3181c38c25
   PubMed Web of Science ®Google Scholar
• Boom M, Niesters M, Sarton E, et al. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18(37):5994–6004. DOI:https://doi.org/10.2174/138161212803582469
   PubMed Web of Science ®Google Scholar
• Streicher JM, Bilsky EJ. Peripherally acting μ-opioid receptor antagonists for the treatment of opioid-related side effects: mechanism of action and clinical implications. J Pharm Pract. 2018;31(6):658–669. DOI:https://doi.org/10.1177/0897190017732263
   PubMed Web of Science ®Google Scholar